Stay tuned and learn Genekor’s latest news and updates on Molecular Oncology.
Οur latest article "Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients" has been published in full text.read more
The poster of the study conducted by Genekor’s Scientific Team "Different Copy Number Variations (CNVs) account for 10.4% of pathogenic variants in 1418 patients referred for hereditary breast cancer testing" was presented at the San Antonio Breast Cancer Symposium 2021.read more
Daphne Karavokyri shares her new documentary on Hereditary Cancer and the HerediGene genetic test she undertook at Genekor.read more
Article in "The Doctor" magazine by members of the scientific research team of hereditary cancer of Genekor Medical.They write: Konstantinos Agiannitopoulos Molecular Biologist, MSc, PhD & Despina Apostolopoulou Molecular Biologist, MSc, PhDread more
Today Genekor is at the front line of modern medicine.read more
RxPONDER Study Results Demonstrate that the Oncotype DX®
Test Can Now Spare Chemotherapy Use in the Majority of Women
with Node-positive Early-stage Breast Cancer.